Document Detail


Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information.
MedLine Citation:
PMID:  20693296     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The level of minimal residual disease (MRD) in acute myeloid leukemia (AML) at early time points (TPs) may be an important prognostic factor. Although internal tandem duplication of FLT3 (FLT3-ITD) as an MRD marker has been questioned for its instability based on semi-quantitative methods, we hypothesized that FLT3-ITD dynamics measured by sensitive quantitative real-time PCR at early TPs before appearance of instability may provide prognostic information.
PATIENTS AND METHODS: We measured mutant quantity in 493 serial samples from 55 patients with a median follow-up time of 64.8 months. The FLT3-ITD quantities after induction (TP1) and after the first post-induction chemotherapy (TP2) were analyzed.
RESULTS: We found that lower FLT3-ITD levels at TP2 predicted longer overall survival (OS) and disease-free survival (DFS) regardless of cytogenetic risk. Multivariate analysis showed that ≥3 log reduction of FLT3-ITD at TP2 independently predicted better DFS and a trend toward better OS. FLT3-ITD disappeared at relapse in 16.7% of patients and none in those harboring mutant NPM1 compared with 29.4% in those with wild-type NPM1 (P = 0.032).
CONCLUSIONS: Though the mutation may disappear at relapse in a few patients, FLT3-ITD levels at early TPs after chemotherapy provide prognostic information. FLT3-ITD is significantly more stable in those with mutant NPM1.
Authors:
W-C Chou; H-A Hou; C-Y Liu; C-Y Chen; L-I Lin; Y-N Huang; Y-C Chao; C-A Hsu; C-F Huang; H-F Tien
Related Documents :
21651316 - Consecutive daily low-dose s-1 adjuvant chemotherapy after radical treatment for squamo...
15217926 - A novel effective and safe consolidation for patients over 60 years with acute myeloid ...
16497826 - Shifting to outpatient management of acute myeloid leukemia: a prospective experience.
14510946 - The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplas...
11948296 - Video-assisted thoracoscopic surgery for diagnosis, staging, and management of lung can...
16505426 - Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally ...
Publication Detail:
Type:  Journal Article     Date:  2010-08-06
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  22     ISSN:  1569-8041     ISO Abbreviation:  Ann. Oncol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  696-704     Citation Subset:  IM    
Affiliation:
Department of Laboratory Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prenatal protein restriction leads to a disparity between aortic and peripheral blood pressure in Wi...
Next Document:  Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma...